EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion

Ivayla Apostolova, Sabine Hellwig, Amir Karimzadeh, Susanne Klutmann, Philipp T Meyer, Ralph Buchert iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-024-06989-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Ivayla Apostolova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. Hauptthemen laut MEDLINE: Dopamine Plasma Membrane Transport Proteins, Tomography, Emission-Computed, Single-Photon, Venlafaxine Hydrochloride, Bupropion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study examined the impact of venlafaxine and bupropion on the detection of nigrostriatal degeneration by dopamine transporter (DAT)-SPECT.

Methods

43 patients (70.7 ± 8.6y, 44% female) with [ 123 I]FP-CIT-SPECT under venlafaxine ( n = 26, 37.5-225 mg/d), bupropion ( n = 16, 150 or 300 mg/d) or both ( n = 1) were included retrospectively. The striatal specific [ 123 I]FP-CIT binding ratio (SBR), its left–right asymmetry and the putamen-to-caudate ratio were transformed to z-scores and submitted to a cluster analysis for data-driven categorization.

Results

Two clusters were identified. The first cluster (37% cases) showed a Parkinson’s disease (PD)-like pattern: median striatal SBR/asymmetry/putamen-to-caudate z-score -4.5/4.9/-3.8. The second cluster (63%) showed symmetric reduction with normal intra-striatal gradient: median striatal SBR/asymmetry/putamen-to-caudate z-score -2.7/0.4/0.2. Patients with follow-up clinical reference diagnoses of neurodegenerative ( n = 8) and non-neurodegenerative ( n = 16) parkinsonism fell exclusively into the former or the latter cluster, respectively ( p < 0.001).

Conclusion

Venlafaxine and bupropion cause uniform reduction of the striatal [ 123 I]FP-CIT SBR that can be distinguished from PD-like reductions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dopamine Plasma Membrane Transport ProteinsTomography, Emission-Computed, Single-PhotonVenlafaxine HydrochlorideBupropionSubstantia NigraHumansFemaleMaleAgedDrug InteractionsRetrospective StudiesTropanesMiddle AgedParkinson Disease

Stichwörter der Autor:innen

BupropionDopamine transporterDrug interactionVenlafaxine[123I]FP-CIT

Substanzen

Dopamine Plasma Membrane Transport ProteinsVenlafaxine HydrochlorideBupropion2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropaneTropanes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
  • Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Freiburg, Germany.
  • Department of Nuclear Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. r.buchert@uke.de.

ORCID-Profile: Ralph Buchert

Förderung

  • Universitätsklinikum Hamburg-Eppendorf (UKE)

Zitieren

APA

Apostolova, I., Hellwig, S., Karimzadeh, A., Klutmann, S., Meyer, P. T., & Buchert, R. (2025). Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06989-z

Vancouver

Apostolova I, Hellwig S, Karimzadeh A, Klutmann S, Meyer PT, Buchert R. Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-06989-z

BibTeX
@article{Apostolova2025,
  author = {Apostolova, Ivayla and Hellwig, Sabine and Karimzadeh, Amir and Klutmann, Susanne and Meyer, Philipp T and Buchert, Ralph},
  title = {Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-024-06989-z}
}
Kostenlos starten →